Ascendis Pharma Gets FDA Letter Noting Deficiencies in Trans

By Chris Wack


Ascendis Pharma A/S said Monday that the U.S. Food & Drug Administration has found deficiencies in the company's new drug application for TransCon PTH, its candidate for the... | April 3, 2023

Related Keywords

Copenhagen , Køavn , Denmark , Chris Wack , Ascendis Pharma , European Commission , Us Food Drug Administration , Us Expanded Access Program For Transcon , European Medicines Agency , Drug Administration , Access Program , European Medicines , Dow Jones , Ascendis Pharmaas Stock Exchange , News , Information , Press Release , Y , Chris , Back , Ascendis , Dharma , Aid , Monday , Hat , The , Wood , Drug , Administration , Gas , Hound , Deficiencies , N , Few , Application , Or , Transcon , Its , Candidate , Or Asnd Us04351p1012 ,